Posts

PAHO: Americas Lose Measles-Free Status as Cases Surge

The region of the Americas loses measles elimination as outbreaks surge in Canada, Mexico, and the US, forcing urgent calls for restored coverage, surveillance, and rapid response. Medscape News Europe source https://www.medscape.com/viewarticle/paho-americas-lose-measles-free-status-cases-surge-2025a1000wfw?src=rss

Pulse Steroids Plus MMF Benefit Juvenile Dermatomyositis

IVMP plus mycophenolate mofetil as first-line therapy produced a high remission rate with sustained muscle and skin improvements in a study of children with dermatomyositis. Medscape Medical News source https://www.medscape.com/viewarticle/juvenile-dermatomyositis-remission-rates-high-intermittent-2025a1000wbc?src=rss

Can Anticoagulants Cut Stroke Risk in Seniors With AF?

Initiation of anticoagulants is not linked to a reduced risk for ischemic stroke in older patients with atrial fibrillation, a retrospective analysis of Medicare beneficiaries shows. Medscape Medical News source https://www.medscape.com/viewarticle/can-anticoagulants-cut-stroke-risk-seniors-atrial-2025a1000wbp?src=rss

Cognition Improved With Some Drugs for Depression

Antidepressant choice or strategy may not alter overall cognition in older adults with treatment-resistant depression, but some drugs may modestly improve inhibitory control. Medscape Medical News source https://www.medscape.com/viewarticle/cognition-improved-some-drugs-depression-2025a1000wbk?src=rss

Phone Use at Night Signals Next-Day Suicidal Behavior Risk

Late-night use of smartphones signals an elevated risk for suicidal ideation and planning the next day in adults at a high risk for suicide, while middle-of-the-night active engagement appears protective. Medscape Medical News source https://www.medscape.com/viewarticle/phone-use-night-signals-next-day-suicidal-behaviors-high-2025a1000w63?src=rss

GLP-1 RAs Effective for Weight Loss in T1D and Obesity

Tirzepatide, semaglutide, and liraglutide lead to weight loss in adults with obesity and T1D over 1 year; the greatest weight loss and a modest decrease in A1c levels are seen with tirzepatide. Medscape Medical News source https://www.medscape.com/viewarticle/glp-1-receptor-agonists-effective-weight-loss-type-1-2025a1000w65?src=rss